Market Closed -
Nyse
04:00:02 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
9.22
USD
|
+2.22%
|
|
+4.42%
|
-0.97%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
120.9
|
99.39
|
981.5
|
1,044
|
692.1
|
659.6
|
-
|
-
|
Enterprise Value (EV)
1 |
567.1
|
99.39
|
1,440
|
1,378
|
692.1
|
1,093
|
1,146
|
1,160
|
P/E ratio
|
-1.22
x
|
-0.96
x
|
-2.51
x
|
4.96
x
|
25.2
x
|
32.4
x
|
25.5
x
|
23.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.33
x
|
0.28
x
|
1.76
x
|
1.16
x
|
1.17
x
|
1.24
x
|
1.19
x
|
1.17
x
|
EV / Revenue
|
1.55
x
|
0.28
x
|
2.59
x
|
1.53
x
|
1.17
x
|
2.06
x
|
2.07
x
|
2.05
x
|
EV / EBITDA
|
8.18
x
|
1.52
x
|
7.54
x
|
3.32
x
|
5.22
x
|
8.57
x
|
7.98
x
|
7.96
x
|
EV / FCF
|
-16.7
x
|
-3.01
x
|
27.4
x
|
4.6
x
|
-
|
155
x
|
32.8
x
|
18.4
x
|
FCF Yield
|
-5.98%
|
-33.2%
|
3.65%
|
21.8%
|
-
|
0.65%
|
3.05%
|
5.43%
|
Price to Book
|
0.48
x
|
0.66
x
|
2.15
x
|
1.97
x
|
1.31
x
|
1.3
x
|
1.31
x
|
1.36
x
|
Nbr of stocks (in thousands)
|
37,417
|
38,112
|
88,824
|
78,497
|
74,344
|
71,544
|
-
|
-
|
Reference price
2 |
3.231
|
2.608
|
11.05
|
13.30
|
9.310
|
9.220
|
9.220
|
9.220
|
Announcement Date
|
2/24/20
|
2/24/21
|
2/23/22
|
2/22/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
365.1
|
351.3
|
556.2
|
901.7
|
593.7
|
530.5
|
553.3
|
564.6
|
EBITDA
1 |
69.34
|
65.48
|
191
|
414.7
|
132.7
|
127.5
|
143.7
|
145.7
|
EBIT
1 |
-39.09
|
-15.54
|
101
|
308.4
|
51.78
|
54.07
|
71.61
|
70.91
|
Operating Margin
|
-10.71%
|
-4.42%
|
18.17%
|
34.2%
|
8.72%
|
10.19%
|
12.94%
|
12.56%
|
Earnings before Tax (EBT)
1 |
-84.34
|
-66.66
|
38.99
|
269.5
|
33.9
|
14.18
|
33.47
|
38.1
|
Net income
1 |
-96.44
|
-99.42
|
-220
|
230.3
|
27.92
|
7.845
|
26.64
|
32.26
|
Net margin
|
-26.42%
|
-28.3%
|
-39.55%
|
25.55%
|
4.7%
|
1.48%
|
4.81%
|
5.71%
|
EPS
2 |
-2.646
|
-2.715
|
-4.400
|
2.680
|
0.3700
|
0.2843
|
0.3621
|
0.3998
|
Free Cash Flow
1 |
-33.92
|
-32.98
|
52.5
|
299.8
|
-
|
7.057
|
35
|
63
|
FCF margin
|
-9.29%
|
-9.39%
|
9.44%
|
33.25%
|
-
|
1.33%
|
6.33%
|
11.16%
|
FCF Conversion (EBITDA)
|
-
|
-
|
27.48%
|
72.31%
|
-
|
5.53%
|
24.35%
|
43.24%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
130.16%
|
-
|
89.95%
|
131.38%
|
195.3%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/20
|
2/24/21
|
2/23/22
|
2/22/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
190.2
|
199
|
284.8
|
184.3
|
233.7
|
181
|
165.8
|
114.3
|
132.6
|
138.2
|
147
|
104.5
|
138.3
|
143.6
|
156.2
|
EBITDA
1 |
90.1
|
101.1
|
158.1
|
49.93
|
105.5
|
51.01
|
47.12
|
9.199
|
25.13
|
32.6
|
40.22
|
17.42
|
39.54
|
39.27
|
43.71
|
EBIT
1 |
69.69
|
79.97
|
132.7
|
13.07
|
82.68
|
30.54
|
27.5
|
-9.499
|
3.245
|
11.26
|
19.16
|
-2.145
|
15.77
|
22.53
|
25.03
|
Operating Margin
|
36.63%
|
40.19%
|
46.58%
|
7.09%
|
35.39%
|
16.87%
|
16.58%
|
-8.31%
|
2.45%
|
8.15%
|
13.03%
|
-2.05%
|
11.41%
|
15.69%
|
16.02%
|
Earnings before Tax (EBT)
1 |
37.71
|
69.88
|
123.8
|
3.092
|
72.77
|
21.8
|
28.07
|
-12.98
|
-2.996
|
6.226
|
10.93
|
-13.52
|
10.29
|
13.95
|
18.95
|
Net income
1 |
42.01
|
58.77
|
103.4
|
2.312
|
65.87
|
15.9
|
25.1
|
-7.726
|
-5.347
|
5.623
|
8.217
|
-9.973
|
7.81
|
10.55
|
14.2
|
Net margin
|
22.08%
|
29.53%
|
36.31%
|
1.25%
|
28.19%
|
8.79%
|
15.13%
|
-6.76%
|
-4.03%
|
4.07%
|
5.59%
|
-9.55%
|
5.65%
|
7.35%
|
9.09%
|
EPS
2 |
0.4700
|
0.6500
|
1.150
|
0.0300
|
0.8300
|
0.2100
|
0.3300
|
-0.1000
|
-0.0700
|
0.0800
|
0.1249
|
-0.1222
|
0.1256
|
0.1345
|
0.1704
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/23/22
|
5/3/22
|
7/27/22
|
11/1/22
|
2/22/23
|
5/2/23
|
7/26/23
|
11/1/23
|
3/5/24
|
4/29/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
446
|
-
|
458
|
334
|
-
|
433
|
487
|
500
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.434
x
|
-
|
2.399
x
|
0.8057
x
|
-
|
3.395
x
|
3.386
x
|
3.433
x
|
Free Cash Flow
1 |
-33.9
|
-33
|
52.5
|
300
|
-
|
7.06
|
35
|
63
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
54.5%
|
-
|
5.61%
|
4.91%
|
5.79%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
1.85%
|
2.07%
|
2.71%
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
423.5
|
1,289
|
1,190
|
Book Value Per Share
2 |
6.790
|
3.940
|
5.130
|
6.760
|
7.090
|
7.110
|
7.020
|
6.760
|
Cash Flow per Share
2 |
-
|
-
|
-
|
4.020
|
-
|
1.450
|
1.170
|
1.270
|
Capex
1 |
36.1
|
30.5
|
35.1
|
45.8
|
-
|
73.8
|
64.5
|
61.9
|
Capex / Sales
|
9.88%
|
8.67%
|
6.32%
|
5.08%
|
-
|
13.91%
|
11.66%
|
10.96%
|
Announcement Date
|
2/24/20
|
2/24/21
|
2/23/22
|
2/22/23
|
3/5/24
|
-
|
-
|
-
|
Last Close Price
9.22
USD Average target price
9.844
USD Spread / Average Target +6.77% Consensus |
1st Jan change
|
Capi.
|
---|
| -0.97% | 660M | | -1.30% | 76.24B | | +0.48% | 47.61B | | +0.83% | 32.43B | | +10.01% | 18.39B | | +11.41% | 11.77B | | -15.96% | 10.95B | | +0.84% | 10.94B | | -0.10% | 9.21B | | -8.07% | 8.06B |
Diversified Chemicals
|